<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38449463</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2807-2618</ISSN><JournalIssue CitedMedium="Internet"><Volume>1</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Narra J</Title><ISOAbbreviation>Narra J</ISOAbbreviation></Journal><ArticleTitle>Persistence of long COVID symptoms in COVID-19 survivors worldwide and its potential pathogenesis - A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e36</StartPage><MedlinePgn>e36</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e36</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.52225/narraj.v1i2.36</ELocationID><Abstract><AbstractText>The study sought to determine the prevalence of persistent long COVID symptoms such as anxiety, depression, dizziness, chest pain, sleep difficulty, palpitations, weight loss, and hair loss among coronavirus disease 2019 (COVID-19) survivors worldwide and to discuss the potential pathogeneses. Potential studies were searched in three databases (PubMed, Scopus, and Web of Science) as of January 30, 2021. Data on study characteristics, patient characteristics during the follow-up, the number of patients with persistent long COVID symptoms and total COVID-19 survivors were collected according to PRISMA guidelines. To assess the quality of studies, the Newcastle-Ottawa scale was used. The estimated prevalence of each long COVID symptom and the association between COVID-19 severity and the occurrence of prolonged symptoms was assessed, if appropriate. The global prevalence of prolonged anxiety was 15.76% (95%CI: 6.36%, 25.15%). Chest pain persisted in 10.36% (239/3,224) of COVID-19 patients (95%CI: 4.92%, 15.80%). Prolonged depression was found in 24 of 548 COVID-19 survivors with an estimated prevalence of 4.32% (95%CI: 2.62%, 6.03%) and dizziness was presented in 4.83% (118/2,219, 95%CI: 1.50%, 8.16%) after recovery. Hair loss was complained by 527 of 2,251 recovered patients (cumulative prevalence of 24.76%, 95%CI: 19.60%, 29.91%), while weight loss was identified in 37 cases among 452 COVID-19 survivors (8.19%, 95%CI: 5.66%, 10.71%). Prolonged palpitation was experienced by 19.38% (211/1,926) survivors with 95%CI: 2.40%, 41.16%. Sleep difficulty was found in 541 of 2,622 COVID-19 survivors (17.87%, 95%CI: 7.55%, 28.20%). The association between COVID-19 severity and the occurrence of persistent long COVID symptoms was not analyzed due to the lack of data. In conclusion, persistent psychological symptoms are frequently reported among COVID-19 survivors. Follow-up studies with a longer duration and larger population are warranted to assess the extent of prolonged symptoms and the quality of life of COVID-19 survivors. Despite various potential pathogeneses that have been hypothesized, a definitive mechanism is yet to be addressed. PROSPERO registration: CRD42021247172.</AbstractText><CopyrightInformation>&#xa9; 2021 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fahriani</LastName><ForeName>Marhami</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ilmawan</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Universitas Brawijaya, Malang, East Java, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fajar</LastName><ForeName>Jonny K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maliga</LastName><ForeName>Helnida A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Universitas Brawijaya, Malang, East Java, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frediansyah</LastName><ForeName>Andri</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Division for Natural Product Technology (BPTBA), Indonesian Institute of Sciences (LIPI), Wonosari, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masyeni</LastName><ForeName>Sri</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine and Health Sciences Universitas Warmadewa, Denpasar, Bali, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Sanjiwani Hospital, Denpasar, Bali, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yusuf</LastName><ForeName>Hanifah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nainu</LastName><ForeName>Firzan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, Hasanuddin University, Makassar, South Sulawesi, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosiello</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Disease, Sapienza-University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sirinam</LastName><ForeName>Salin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keam</LastName><ForeName>Synat</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Western Australia, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ophinni</LastName><ForeName>Youdiil</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Ragon Institute of MGH, MIT and Harvard, Harvard Medical School, Harvard University, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.6084/m9.figshare.14371784</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Indonesia</Country><MedlineTA>Narra J</MedlineTA><NlmUniqueID>9918625888906676</NlmUniqueID><ISSNLinking>2807-2618</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">follow-up study</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">prolonged symptom</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>7</Day><Hour>3</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38449463</ArticleId><ArticleId IdType="pmc">PMC10914031</ArticleId><ArticleId IdType="doi">10.52225/narraj.v1i2.36</ArticleId><ArticleId IdType="pii">NarraJ-1-e36</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19 coronavirus pandemic. Available from: https://www.worldometers.info/coronavirus/ (Accessed: 11 March, 2021).</Citation></Reference><Reference><Citation>Nicola M, Alsafi Z, Sohrabi C, et al. . The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int J Surg 2020; 78:185&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162753</ArticleId><ArticleId IdType="pubmed">32305533</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin A, Markhvida M, Hallegatte S, et al. . Socio-Economic impacts of COVID-19 on household consumption and poverty. Econ Disaster Clim Chang 2020; 4(3):1&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7376321</ArticleId><ArticleId IdType="pubmed">32838120</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene CJ, Burleson SL, Crosby JC, et al. . Coronavirus disease 2019: International public health considerations. J Am Coll Emerg Physicians Open 2020; 1(2):70&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228375</ArticleId><ArticleId IdType="pubmed">32427157</ArticleId></ArticleIdList></Reference><Reference><Citation>Lew HL, Oh-Park M, Cifu DX. The war on covid-19 pandemic: role of rehabilitation professionals and hospitals. Am J Phys Med Rehabil 2020; 99(7):571&#x2013;572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7268823</ArticleId><ArticleId IdType="pubmed">32371624</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannakeas V, Bhatia D, arkentin MT, et al. . Estimating the maximum capacity of COVID-19 cases manageable per day given a health care system&#x2019;s constrained resources. Ann Intern Med 2020; 173(5):407&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179996</ArticleId><ArticleId IdType="pubmed">32298412</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahriani M, Anwar S, Yufika A, et al. . Disruption of childhood vaccination during the COVID-19 pandemic in Indonesia. Narra J 2021; 1(1):e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10914023</ArticleId><ArticleId IdType="pubmed">38449777</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhanot D, Singh T, Verma SK, et al. . Stigma and Discrimination During COVID-19 Pandemic. Front Public Health 2020; 8(829):577018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7874150</ArticleId><ArticleId IdType="pubmed">33585379</ArticleId></ArticleIdList></Reference><Reference><Citation>Badrfam R, Zandifar A.. Stigma Over COVID-19; New conception beyond individual sense. Arch Med Res 2020; 51(6):593&#x2013;594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237948</ArticleId><ArticleId IdType="pubmed">32467051</ArticleId></ArticleIdList></Reference><Reference><Citation>Badrfam R, Zandifar A.. COVID-19 and melancholia: different perception of the concept of stigma and loss. Iran J Psychiatry 2020; 15(3):264&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7603591</ArticleId><ArticleId IdType="pubmed">33193779</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R, Subedi M.. COVID-19 and stigma: Social discrimination towards frontline healthcare providers and COVID-19 recovered patients in Nepal. Asian J Psychiatr 2020; 53:102222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7293527</ArticleId><ArticleId IdType="pubmed">32570096</ArticleId></ArticleIdList></Reference><Reference><Citation>Dye TD, Alcantara L, Siddiqi S, et al. . Risk of COVID-19-related bullying, harassment and stigma among healthcare workers: an analytical cross-sectional global study. BMJ Open 2020; 10(12):e046620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7780430</ArticleId><ArticleId IdType="pubmed">33380488</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, et al. . Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020; 7(7):611&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>McKay D, Heisler M, Mishori R, et al. . Attacks against health-care personnel must stop, especially as the world fights COVID-19. The Lancet 2020; 395(10239):1743&#x2013;1745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7239629</ArticleId><ArticleId IdType="pubmed">32445692</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei Q, Wang F, Bryant A, et al. . Mental health problems among COVID-19 survivors in uhan, China. orld Psychiatry 2021; 20(1):139&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7801855</ArticleId><ArticleId IdType="pubmed">33432745</ArticleId></ArticleIdList></Reference><Reference><Citation>Park HY, Jung J, Park HY, et al. . Psychological consequences of survivors of COVID-19 pneumonia 1 month after discharge. J Korean Med Sci 2020; 35(47):e409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7721563</ArticleId><ArticleId IdType="pubmed">33289371</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai X, Hu X, Ekumi IO, et al. . Psychological distress and its correlates among COVID-19 survivors during early convalescence across age groups. Am J Geriatr Psychiatry 2020; 28(10):1030&#x2013;1039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347493</ArticleId><ArticleId IdType="pubmed">32753338</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun N, ei L, Wang H, et al. . Cualitative study of the psychological experience of COVID-19 patients during hospitalization. J Affect Disord 2021; 278:15&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7444461</ArticleId><ArticleId IdType="pubmed">32949869</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med 2021; 27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al. . Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect 2021; 27(2):258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Akinci T, Basar H Melek. Relationship between sleep quality and the psychological status of patients hospitalised with COVID-19. Sleep Med 2021; 80:167&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7842153</ArticleId><ArticleId IdType="pubmed">33601228</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal A, Iqbal K, Arshad Ali S, et al. . The COVID-19 sequelae: a cross-sectional evaluation of post-recovery symptoms and the need for rehabilitation of covid-19 survivors. Cureus 2021; 13(2):e13080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7932827</ArticleId><ArticleId IdType="pubmed">33680620</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Plos Med 2009; 6(7):e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020. In.: World Health Organization; 2020.</Citation></Reference><Reference><Citation>China National Health Commission. Chinese clinical guidance for COVID-19 pneumonia diagnosis and treatment. 2020.</Citation></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25(9):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane T. Review Manager (RevMan) 5.3. Copenhagen: The Nordic Cochrane Centre 2008; 373.</Citation></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Cellai M, O&#x2019;Keefe JB. Characterization of prolonged COVID-19 symptoms in an outpatient telemedicine clinic. Open Forum Infect Dis 2020; 7(10):ofaa420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543492</ArticleId><ArticleId IdType="pubmed">33117851</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al. . Clinical sequelae of COVID-19 survivors in uhan, China: a single-centre longitudinal study. Clin Microbiol Infect 2021; 27(1):89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu HQ, Yuan B, An YW, et al. . Clinical characteristics and follow-up analysis of 324 discharged COVID-19 patients in Shenzhen during the recovery period. Int J Med Sci 2021; 18(2):347&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7757147</ArticleId><ArticleId IdType="pubmed">33390803</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan N, Wang W, Gao Y, et al. . Medium term follow-up of 337 patients with coronavirus disease 2019 (COVID-19) in a Fangcang Shelter Hospital in uhan, China. Front Med (Lausanne) 2020; 7:373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347902</ArticleId><ArticleId IdType="pubmed">32719806</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo R, Conte C, Lanzani C, et al. . Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study. PLoS One 2020; 15(10):e0239570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556454</ArticleId><ArticleId IdType="pubmed">33052920</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L-p, Wang J, ie R-h, et al. . The effects of traditional Chinese Medicine as an auxiliary treatment for COVID-19: A systematic review and meta-analysis. The Journal of Alternative and Complementary Medicine 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33252246</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy C, Lassailly G, Parmentier E, et al. . Caution with the use of lopinavir/ritonavir in severely ill patients for the treatment of SARS-CoV-2: A report of severe jaundice. The American Journal of Gastroenterology 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7473797</ArticleId><ArticleId IdType="pubmed">32858566</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L, Yang B, Jiang N, et al. . Three-month Follow-up study of survivors of coronavirus disease 2019 after discharge. J Korean Med Sci 2020; 35(47):e418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7721559</ArticleId><ArticleId IdType="pubmed">33289374</ArticleId></ArticleIdList></Reference><Reference><Citation>Sami R, Soltaninejad F, Amra B, et al. . A one-year hospital-based prospective COVID-19 open-cohort in the Eastern Mediterranean region: The Khorshid COVID Cohort (KCC) study. PLoS One 2020; 15(11):e0241537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7644058</ArticleId><ArticleId IdType="pubmed">33151983</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabatabaei SMH, Rajebi H, Moghaddas F, et al. . Chest CT in COVID-19 pneumonia: what are the findings in mid-term follow-up? Emerg Radiol 2020; 27(6):711&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7649573</ArticleId><ArticleId IdType="pubmed">33165674</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, et al. . Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324(6):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazato Y, Morioka S, Tsuzuki S, et al. . Prolonged and late-onset symptoms of coronavirus disease 2019. Open Forum Infect Dis 2020; 7(11):ofaa507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665672</ArticleId><ArticleId IdType="pubmed">33230486</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Tan C, Xu J, et al. . Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res 2020; 21(1):163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323373</ArticleId><ArticleId IdType="pubmed">32600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Ye L, ia R, et al. . Chest computed tomography and clinical follow-up of discharged patients with COVID-19 in enzhou City, Zhejiang, China. Ann Am Thorac Soc 2020; 17(10):1231&#x2013;1237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7640627</ArticleId><ArticleId IdType="pubmed">32692945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, Shang YM, Song B, et al. . Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine 2020; 25:100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, et al. . Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun 2020; 89:594&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillett G, Jordan I.. Severe psychiatric disturbance and attempted suicide in a patient with COVID-19 and no psychiatric history. BMJ Case Rep 2020; 13(10):e239191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10577706</ArticleId><ArticleId IdType="pubmed">33130587</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Lu H, Zeng H, et al. . The differential psychological distress of populations affected by the COVID-19 pandemic. Brain Behav Immun 2020; 87:49&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156946</ArticleId><ArticleId IdType="pubmed">32304883</ArticleId></ArticleIdList></Reference><Reference><Citation>iu J, Shen B, Zhao M, et al. . A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen Psychiatr 2020; 33(2):e100213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7061893</ArticleId><ArticleId IdType="pubmed">32215365</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly M, Robinson E.. Psychological distress and adaptation to the COVID-19 crisis in the United States. J Psychiatr Res 2021; 136:603&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7588823</ArticleId><ArticleId IdType="pubmed">33138985</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q, Wang B, Mao J.. The pathogenesis and treatment of the cytokine storm&#x2019;in COVID-19. J Infection 2020; 80(6):607&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194613</ArticleId><ArticleId IdType="pubmed">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepgul N, Cattaneo A, Agarwal K, et al. . Transcriptomics in interferon-a-treated patients identifies inflammation-, neuroplasticity-and oxidative stress-related signatures as predictors and correlates of depression. Neuropsychopharmacology 2016; 41(10):2502&#x2013;2511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4983179</ArticleId><ArticleId IdType="pubmed">27067128</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou R, Garner M, Holmes C, et al. . Peripheral inflammatory cytokines and immune balance in Generalised Anxiety Disorder: Case-controlled study. Brain Behav Immun 2017; 62:212&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5373436</ArticleId><ArticleId IdType="pubmed">28161475</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubistova A, Horacek J, Novak T.. Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls. Psychiatr Danub 2012; 24 Suppl 1:S153&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">22945211</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Sanchez CM, Diaz-Maroto I, Fernandez-Diaz E, et al. . Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology 2020; 95(8):e1060&#x2013;e1070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichard RR, Kashani KB, Boire NA, et al. . Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol 2020; 140(1):1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7245994</ArticleId><ArticleId IdType="pubmed">32449057</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo L, De Lorenzo R, D&#x2019;Amico M, et al. . COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: A post-hoc analysis of a prospective cohort study. Clin Nutr 2021; 40(4):2420&#x2013;2426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598735</ArticleId><ArticleId IdType="pubmed">33160700</ArticleId></ArticleIdList></Reference><Reference><Citation>Anker MS, Landmesser U, von Haehling S, et al. . eight loss, malnutrition, and cachexia in COVID-19: facts and numbers. In.: Wiley Online Library; 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7890265</ArticleId><ArticleId IdType="pubmed">33382211</ArticleId></ArticleIdList></Reference><Reference><Citation>Laaksonen DE, Niskanen L, Nyyssonen K, et al. . C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 2004; 47(8):1403&#x2013;1410.</Citation><ArticleIdList><ArticleId IdType="pubmed">15309290</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventre J, Doebber T, Xu M, et al. . Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice. Diabetes 1997; 46(9):1526&#x2013;1531.</Citation><ArticleIdList><ArticleId IdType="pubmed">9287059</ArticleId></ArticleIdList></Reference><Reference><Citation>Virgens IP, Santana NM, Lima SC, et al. . Can COVID-19 be a risk for cachexia for patients during intensive care? Narrative review and nutritional recommendations. 2020:1&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7711335</ArticleId><ArticleId IdType="pubmed">33261670</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamir O, Hasselgren P-O, Kunkel SL, et al. . Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. 1992; 127(2):170&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">1540094</ArticleId></ArticleIdList></Reference><Reference><Citation>Clowes Jr G, Hirsch E, George BC, et al. . Survival from sepsis. The significance of altered protein metabolism regulated by proteolysis inducing factor, the circulating cleavage product of interleukin-1. 1985; 202(4):446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1250944</ArticleId><ArticleId IdType="pubmed">3931593</ArticleId></ArticleIdList></Reference><Reference><Citation>ahlin-Larsson B, ilkinson DJ, Strandberg E, et al. . Mechanistic Links Underlying the Impact of C-Reactive Protein on Muscle Mass in Elderly. Cell Physiol Biochem 2017; 44(1):267&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">29130969</ArticleId></ArticleIdList></Reference><Reference><Citation>Fruebis J, Tsao TS, Javorschi S, et al. . Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 2001; 98(4):2005&#x2013;2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC29372</ArticleId><ArticleId IdType="pubmed">11172066</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvin E, Paynter NP, Erlinger TP. The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 2007; 167(1):31&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">17210875</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Xu Z, Li JW, et al. . Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents 2020; 55(5):105954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118634</ArticleId><ArticleId IdType="pubmed">32234467</ArticleId></ArticleIdList></Reference><Reference><Citation>Di--Filippo L, De--Lorenzo R, D&#x2019;Amico M, et al. . COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: A post-hoc analysis of a prospective cohort study. 2021; 40(4):2420&#x2013;2426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598735</ArticleId><ArticleId IdType="pubmed">33160700</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedock D, Bel Lassen P, Mathian A, et al. . Prevalence and severity of malnutrition in hospitalized COVID-19 patients. Clin Nutr ESPEN 2020; 40:214&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7500887</ArticleId><ArticleId IdType="pubmed">33183539</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmukh V, Motwani R, Kumar A, et al. . Histopathological observations in COVID-19: a systematic review. J Clin Pathol 2021; 74(2):76&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">32817204</ArticleId></ArticleIdList></Reference><Reference><Citation>Morley JE, Kalantar-Zadeh K, Anker SD. COVID-19: a major cause of cachexia and sarcopenia? J Cachexia Sarcopenia Muscle 2020; 11(4):863&#x2013;865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300782</ArticleId><ArticleId IdType="pubmed">32519505</ArticleId></ArticleIdList></Reference><Reference><Citation>Trachootham D, Thongyen S, Lam-Ubol A, et al. . Simultaneously Complete but Not Partial Taste and Smell Losses were Associated with SAR-CoV-2 Infection. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8080514</ArticleId><ArticleId IdType="pubmed">33819604</ArticleId></ArticleIdList></Reference><Reference><Citation>Anker SD, Negassa A, Coats AJ, et al. . Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003; 361(9363):1077&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">12672310</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, et al. . Management of post-acute covid-19 in primary care. BMJ 2020; 370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Galal I, Hussein AARM, Amin MT, et al. . Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. The Egyptian Journal of Bronchology 2021; 15(1):10.</Citation></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an International Cohort: 7 months of symptoms and their impact. medRxiv 2021:2020.2012.2024.20248802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallejo N, Teis A, Mateu L, et al. . Persistent chest pain after recovery of COVID-19: microvascular disease-related angina? European Heart Journal-Case Reports 2021; 5(3).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8186924</ArticleId><ArticleId IdType="pubmed">34113774</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw B, Daskareh M, Gholamrezanezhad A.. The lingering manifestations of COVID-19 during and after convalescence: update on long-term pulmonary consequences of coronavirus disease 2019 (COVID-19). Radiol Med 2021; 126(1):40&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529085</ArticleId><ArticleId IdType="pubmed">33006087</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinner CD, Gottlieb RL, Criner GJ, et al. . Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial. Jama 2020; 324(11):1048&#x2013;1057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7442954</ArticleId><ArticleId IdType="pubmed">32821939</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren A, Vano-Galvan S, ambier CG, et al. . A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity. J Cosmet Dermatol 2020; 19(7):1545&#x2013;1547.</Citation><ArticleIdList><ArticleId IdType="pubmed">32301221</ArticleId></ArticleIdList></Reference><Reference><Citation>Mieczkowska K, Deutsch A, Borok J, et al. . Telogen effluvium: a sequela of COVID-19. Int J Dermatol 2021; 60(1):122&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753411</ArticleId><ArticleId IdType="pubmed">33226117</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalli G, De Luca G, Campochiaro C, et al. . Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol 2020; 2(6):e325&#x2013;e331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252085</ArticleId><ArticleId IdType="pubmed">32501454</ArticleId></ArticleIdList></Reference><Reference><Citation>Theobald SJ, Simonis A, Kreer C, et al. . The SARS-CoV-2 spike protein primes inflammasome-mediated interleukin-1-beta secretion in COVID-19 patient-derived macrophages. 2020.</Citation></Reference><Reference><Citation>Huang M, Dulon D, Schacht JJAoO, Rhinology, et al. . Outer hair cells as potential targets of inflammatory mediators. 1990; 99(6_suppl):35&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">2112361</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahe YF, Buan B, Billoni N, et al. . Pro-inflammatory cytokine cascade in human plucked hair. Skin Pharmacol 1996; 9(6):366&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pubmed">9055357</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann R, Eicheler W, Wenzel E, et al. . Interleukin-1-induced inhibition of hair growth in vitro is mediated by cyclic AMP. 1997; 108(1):40&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">8980284</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann R, Happle RJD. Does lnterleukin-1 Induce Hair Loss? 1995; 191(4):273&#x2013;275.</Citation><ArticleIdList><ArticleId IdType="pubmed">8573920</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>